New JAMA Study Underscores Dangers of Influenza
BALTIMORE -- As reported in the January 8 issue of Journal of the American Medical Association (JAMA), deaths associated with influenza have increased substantially in the past two decades in the U.S. The National Foundation for Infectious Diseases wants to remind the American public that there is an effective vaccine to protect against influenza. There is still plenty of vaccine available and NFID encourages those Americans who haven't already received a flu shot to contact their healthcare provider or public health department about immunization.
"The substantial increase in influenza-related deaths over the past two decades due to the aging population points to the need for better prevention measures including vaccination programs for elderly persons," said William Schaffner, MD, NFID, director and professor and chairman, Department of Preventive Medicine, Vanderbilt University School of Medicine.
"It's important for caregivers, family members and healthcare providers -- those who have regular contact with anyone at high risk for complications of influenza -- to also consider vaccination as it may decrease transmission rates to those most likely to die from complications of influenza."
Founded in 1973, NFID is a non-profit organization dedicated to public and professional educational programs about, and in support of, research into causes, treatment and prevention of infectious diseases.
Source: National Foundation for Infectious Diseases
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
